Hepatitis B and C Virus Infections in Hepatocellular Carcinoma and Their Prevention

作者: Ding-Shinn Chen

DOI: 10.1007/978-4-431-68255-4_180

关键词: Hepatitis B virusVirusHepatitis C virusHepatitis BHBsAgVirologyChronic liver diseaseHepatocellular carcinomaHepatitis D virusMedicine

摘要: Although the etiology of chronic liver disease and hepatocellular carcinoma (HCC) varies in different parts world, hepatitis viruses are most important etiologic factor. Recently, use sensitive specific assays, including polymerase chain reaction (PCR), has greatly contributed to understanding HCC. For example, Taiwan, HCC is commonly associated with persistent B virus (HBV) infection, surface antigen (HBsAg) found 80%–90% patients investigated. Hepatitis C (HCV) next common, an anti-HCV prevalence about 70% HBsAg-negative patients. Overall, 10%–15% have dual infections HBV HCV. In HBsAg-negative/anti-HCV-negative patients, HCV-RNA or HBV- DNA can be shown by PCR at least half cases, thus still suggesting role both viruses.

参考文章(40)
Ferruccio Bonino, Maurizia Rossana Brunetto, F Oliveri, Gc Actis, Pathobiology of chronic hepatitis virus infection and hepatocellular carcinoma (HCC). The Italian journal of gastroenterology. ,vol. 23, pp. 498- 502 ,(1991)
Jay H. Hoofnagle, Jules Dienstag, Girish N. Vyas, Viral Hepatitis and Liver Disease ,(1985)
Isaburo Fujimoto, Yoshinori Urano, Aya Hanai, Kunio Okuda, Changing incidence of hepatocellular carcinoma in Japan. Cancer Research. ,vol. 47, pp. 4967- 4972 ,(1987)
Adrian M. DiBisceglie, Robert H. Purcell, Edward Tabor, Etiology, pathology, and treatment of hepatocellular carcinoma in North America Portfolio Pub. Co. , Gulf Pub. Co., Book Division. ,(1991)
T. Stroffolini, M. Chiaramonte, C. Tiribelli, E. Villa, R.G. Simonetti, M. Rapicetta, M.A. Stazi, T. Bertin, S.L. Crocè, P. Trande, A. Magliocco, P. Chionne, Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: Relative risk and population attributable risk from a case-control study in Italy Journal of Hepatology. ,vol. 16, pp. 360- 363 ,(1992) , 10.1016/S0168-8278(05)80670-1
Jin-Chuan Sheu, Guan-Tarn Huang, Ling-Na Shih, Wen-Chen Lee, Huey-Chi Chou, Jin-Town Wang, Po-Huang Lee, Ming-Yang Lai, Chang-Yi Wang, Pei-Ming Yang, Hsuan-Shu Lee, Ding-Shinn Chen, Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma. Gastroenterology. ,vol. 103, pp. 1322- 1327 ,(1992) , 10.1016/0016-5085(92)91523-7
James G. Donahue, Alvaro Muñoz, Paul M. Ness, Donald E. Brown, David H. Yawn, Hugh A. McAllister, Bruce A. Reitz, Kenrad E. Nelson, The Declining Risk of Post-Transfusion Hepatitis C Virus Infection The New England Journal of Medicine. ,vol. 327, pp. 369- 373 ,(1992) , 10.1056/NEJM199208063270601
Dimitrios Trichopoulos, Anastasia Tzonou, Evangelia Kaklamani, Angelos Hatzakis, Nicholas E. Day, Nubia Muñoz, Stefanos Hadziyannis, Loukas Sparos, Delta agent and the etiology of hepatocellular carcinoma. International Journal of Cancer. ,vol. 39, pp. 283- 286 ,(1987) , 10.1002/IJC.2910390303
I. Saito, T. Miyamura, A. Ohbayashi, H. Harada, T. Katayama, S. Kikuchi, Y. Watanabe, S. Koi, M. Onji, Y. Ohta, Hepatitis C virus infection is associated with the development of hepatocellular carcinoma Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 6547- 6549 ,(1990) , 10.1073/PNAS.87.17.6547
Stig Cronberg, Bengt-Göran Hansson, Mohammed Thermos, Torkil Moestrup, Amadou Moustapha Sow, Hepatitis D (delta agent) in primary hepatocellular carcinoma and liver disease in Senegal. Liver. ,vol. 4, pp. 275- 279 ,(2008) , 10.1111/J.1600-0676.1984.TB00937.X